Press release
In-Vitro Transcription Templates Market Trends and Outlook 2024
in-vitro transcription templates market trends
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15838&type=smp
According to The Business Research Company's, The in-vitro transcription templates market size has grown exponentially in recent years. It will grow from $0.82 billion in 2023 to $1.01 billion in 2024 at a compound annual growth rate (CAGR) of 23.4%. The growth in the historic period can be attributed to rise in cases of chronic diseases, increase in investments in R&D in healthcare and pharmaceutical sectors, improvements in gene therapy technology, collaborations and partnerships and developments in gene therapy.
The in-vitro transcription templates market size is expected to see exponential growth in the next few years. It will grow to $2.35 billion in 2028 at a compound annual growth rate (CAGR) of 23.5%. The growth in the forecast period can be attributed to Increase in advancement in biotechnology, rise in focus in R&D activities, rise in usage of in-vitro transcription templates, demand for early diagnosis of diseases and increasing need for mRNA-based vaccines. Major trends in the forecast period include developments in RNA synthesis technologies, technological advancements, advancement in biotechnology, advancements in enzymatic synthesis techniques, and integration of automation and digitalization.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/in-vitro-transcription-templates-global-market-report
Market Drivers and Trends:
The increasing incidence of traumatic brain injuries (TBI) is expected to propel the growth of the external ventricular drain market going forward. Traumatic brain injury (TBI) refers to an injury to the brain caused by an external force, which can result in temporary or permanent impairment of cognitive, physical, and psychosocial functions. The increasing incidence of traumatic brain injuries can be attributed to factors including rising participation in contact sports, higher rates of motor vehicle accidents, and an aging population prone to falls. TBIs can generate elevated intracranial pressure (ICP) due to swelling, hemorrhage, or the collection of cerebrospinal fluid (CSF), all of which can result in additional brain damage. The external ventricular drain (EVD) helps to reduce these consequences by draining excess CSF and regularly monitoring ICP. For instance, in May 2024, according to the Florida Department of Health, a US-based government agency, the age-adjusted death rate from traumatic brain injury in Florida increased from 5,406 per 100,000 population in 2021 to 5,654 per 100,000 population in 2022, indicating a rise of approximately 4.59%. Therefore, the increasing incidence of traumatic brain injuries is driving the growth of the external ventricular drain market.
Major companies operating in the in-vitro transcription templates market are developing self-amplifying RNA synthesis services to enhance the efficiency and effectiveness of RNA-based therapies, reduce production costs, and improve patient outcomes in various therapeutic applications. Self-amplifying RNA synthesis service is a technology that enables the production of RNA capable of replicating itself within host cells, leading to enhanced protein expression from minimal RNA input, thereby improving the efficiency and effectiveness of RNA-based therapies. For instance, in May 2024, GenScript Biotech Corporation, a US-based biotechnology company, launched a self-amplifying RNA (saRNA) synthesis service, expanding its in vitro transcription RNA synthesis portfolio. This new service enhances the potency and efficacy of vaccines, immunotherapies, and gene therapies by enabling robust protein expression from a small amount of RNA. The saRNA platform promises to reduce dosages, lower production costs, and improve patient outcomes. Supported by extensive research and development, GenScript's saRNA exhibits high purity and enhanced protein expression, ensuring reliable performance.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Major Key Players of the Market:
Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Eurofins Genomics LLC, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Integrated DNA Technologies Inc., Promega Corporation, Genescript Biotech Corporation, Takara Bio Inc., New England Biolabs, OriGene Technologies Inc., Cayman Chemical, Synthego Corporation, Synbio Technologies, Creative Diagnostics, VectorBuilder Inc., Bio-Synthesis Inc., TriLink BioTechnologies, Norgen Biotek Corporation, Genaxxon BioScience GmbH, Enzo Life Sciences Inc., GeneCopoeia
In-Vitro Transcription Templates Market 2024 Key Insights:
• The in-vitro transcription templates market size is expected to see exponential growth in the next few years. It will grow to $2.35 billion in 2028 at a compound annual growth rate (CAGR) of 23.5%.
• Gene Therapy Advancements Drive Growth In In-Vitro Transcription Templates Market
• Innovative Advancements In In-Vitro Transcription Technology Transform Biotechnology Landscape
• North America was the largest region in the in-vitro transcription templates market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=15838&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release In-Vitro Transcription Templates Market Trends and Outlook 2024 here
News-ID: 3705430 • Views: …
More Releases from The Business research company
Next-Gen Biometric Authentication Market Size Forecasted To Achieve $25.99 Billi …
The Next-Gen Biometric Authentication Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Next-Gen Biometric Authentication Market Size and Projected Growth Rate?
The market size for next-generation biometric authentication has seen an impressive increase in recent times. The market is projected to expand from…
Rising Cases Of Premature Births Driving Growth In The Market Due To Increasing …
The Necrotizing Enterocolitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Necrotizing Enterocolitis Market Size and Its Estimated Growth Rate?
The market for necrotizing enterocolitis has seen a robust expansion in recent years. Projected to escalate from $4.83 billion in 2024 to…
Multi-Axis Force Torque Sensor Market Forecast 2025-2034: Comprehensive Analysis …
The Multi-Axis Force Torque Sensor Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Multi-Axis Force Torque Sensor Market?
In recent times, the market size for the multi-axis force torque sensor has shown substantial growth. It is projected to expand…
Evolving Market Trends In The Metal Power Transmission Chain Industry: Innovativ …
The Metal Power Transmission Chain Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Metal Power Transmission Chain Market Size During the Forecast Period?
Recent years have seen a robust growth in the size of the metal power transmission chain market. Expected to…
More Releases for RNA
Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand.
Browse 156 Market Data Tables and 112 Figures spread through 175…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited.
Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring…
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year.
Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved…
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018!
Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led…
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion.
One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and…
